GPC
51
-2
CPB
35
-4
RCL
66
-3
KMI
67
4
DVA
47
-4
NKE
33
2
TAP
35
-2
MSI
49
5
DG
68
-6
MU
76
-3
TXN
50
-2
T
26
3
SPG
50
2
NVDA
59
4
SBUX
37
-3
PCG
74
-3
XYL
33
-2
AMT
26
2
XRAY
25
-4
DE
43
-2
GPC
51
-2
CPB
35
-4
RCL
66
-3
KMI
67
4
DVA
47
-4
NKE
33
2
TAP
35
-2
MSI
49
5
DG
68
-6
MU
76
-3
TXN
50
-2
T
26
3
SPG
50
2
NVDA
59
4
SBUX
37
-3
PCG
74
-3
XYL
33
-2
AMT
26
2
XRAY
25
-4
DE
43
-2
Financhill
Back

ProShares Ultra Financials Vs. Structure Therapeutics, Inc. Industry Stock Comparison

Buy
82

UYG
ProShares Ultra Financials

Last Price:
$103.82
Seasonality Move:
2.03%
Buy
63

GPCR
Structure Therapeutics, Inc.

Last Price:
$71.39
Seasonality Move:
-34.19%
Buy
82
ProShares Ultra Financials (UYG) is a Buy

Is ProShares Ultra Financials a Buy, Sell or Hold?

  • The current ProShares Ultra Financials [UYG] share price is $103.49. The Score for UYG is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
  • UYG is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
63
Structure Therapeutics, Inc. (GPCR) is a Buy

Is Structure Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Structure Therapeutics, Inc. [GPCR] share price is $71.29. The Score for GPCR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

UYG Stock Price Chart

What is ProShares Ultra Financials's stock price today?

  • The ProShares Ultra Financials share price today is $103.49
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UYG is experiencing buying pressure, which is a positive indicator for future bullish movement.

GPCR Stock Price Chart

What is Structure Therapeutics, Inc.'s stock price today?

  • The Structure Therapeutics, Inc. share price today is $71.29
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

UYG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 22.58 Buy
Relative Strength Index (14 RSI): 68.46 Buy
Chaikin Money Flow: 15154 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (91.56 - 100.44) Buy
Bollinger Bands (100): (92.87 - 99.29) Buy

GPCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.5 Buy
Relative Strength Index (14 RSI): 72.85 Buy
Chaikin Money Flow: 1903413 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.41 - 65.27) Buy
Bollinger Bands (100): (17 - 45.24) Buy

UYG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 101.21 Buy
20-day SMA: 97.66 Buy
50-day SMA: 95.14 Buy
200-day SMA: 92.15 Buy
8-day EMA: 64.37 Buy
20-day EMA: 33.42 Buy
50-day EMA: 14.97 Buy
200-day EMA: 3.97 Buy

GPCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 64.43 Buy
20-day SMA: 52.92 Buy
50-day SMA: 40.28 Buy
200-day SMA: 26.09 Buy
8-day EMA: 64 Buy
20-day EMA: 55.88 Buy
50-day EMA: 44.22 Buy
200-day EMA: 31.26 Buy

ProShares Ultra Financials Earnings Growth & UYG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.10 per share.

ProShares Ultra Financials Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Structure Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):